Theralase Technologies Inc (TSX-V:TLT, OTCQB:TLTFF), a clinical-stage pharmaceutical company, announced its proposal to extend the expiry date of 10 million share purchase warrants from September 22, 2024, to September 22, 2027.
The warrants, issued on September 22, 2022, as part of a private placement, are exercisable at $0.35 per share. All other terms and conditions remain unchanged.